NCT01886235View on ClinicalTrials.gov

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 4, 2013

Primary Completion Date

June 16, 2015

Study Completion Date

May 6, 2020

Conditions
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin MelanomaStage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin MelanomaStage IV Skin Melanoma
Interventions
PROCEDURE

Diagnostic Microscopy

Undergo intravital microscopy

DRUG

Fluorescein Sodium Injection

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT01886235 - Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery | Biotech Hunter | Biotech Hunter